Blood Cancer Clinical Trials

Clinical trials are approach to discover effective treatments and delivery method. Currently phase I trial of Darinaparsin, an organic arsenical for relapsed leukemic, myeloma, myelodysplasia, lymphoproliferative cancers has been completed.

Clinical trials are going with azactdine on phase I, however currently patients are being recruiting for Non-hodgkin lymphoma, myeloma.

Related Journals of Blood Cancer Clinical Trials

Clinical & Experimental Oncology, Cancer Surgery, Cancer Science & Therapy journal, Cancer Research journal, Blood Cancer Journal, Journal of Cancer Science & Therapy, Blood, British Journal of Cancer, ISRN Oncology, Journal of Leukemia.